A Dual Role of Osteopontin in Modifying B Cell Responses

Area of Science:

• Neuroimmunology
• Cellular immunology

Background:

• B cell aggregates in the central nervous system (CNS) are implicated in secondary progressive multiple sclerosis (MS).
• The molecular mechanisms driving B cell aggregate formation and persistence in MS remain unclear.

Purpose of the Study:

• To investigate the expression pattern of osteopontin (OPN) in MS brain tissue and its role in B cell aggregate modulation.
• To elucidate the functional effects of OPN on B cells.

Main Methods:

• Screening of autopsied MS brain sections for CD20+ B cell aggregates and OPN co-expression.
• In vitro studies using peripheral blood from healthy volunteers, including flow cytometry, ELISA, and cell aggregation assays.

Main Results:

• OPN was expressed in MS brain tissue, with high co-expression within B cell aggregates.
• In vitro, OPN downregulated CD80 and CD86 on B cells and reduced IL-6 production.
• OPN-treated B cells showed an increased tendency for homotypic aggregation.

Conclusions:

• OPN exhibits a dual role in modulating B cell responses in the context of MS.
• OPN may influence B cell pathogenicity through both inhibitory and pro-aggregative mechanisms.